Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of “Hold” by Brokerages

Roche Holding AG (OTCMKTS:RHHBY) has been given an average recommendation of “Hold” by the eleven analysts that are currently covering the company, MarketBeat reports. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $60.00.

RHHBY has been the topic of a number of research reports. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a research note on Monday, July 6th. Morgan Stanley raised Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective on the stock in a report on Friday, August 7th. Finally, Zacks Research upgraded Roche from a “strong sell” rating to a “hold” rating in a research report on Monday, August 24th.

Roche Price Performance

RHHBY stock opened at $55.19 on Monday. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. The company has a 50 day simple moving average of $53.94 and a 200 day simple moving average of $52.95. Roche has a 1 year low of $39.50 and a 1 year high of $60.85.

Institutional Trading of Roche

Institutional investors have recently modified their holdings of the business. Puzo Michael J bought a new position in Roche during the 2nd quarter worth $1,229,000. S&CO Inc. grew its position in shares of Roche by 163.0% in the 1st quarter. S&CO Inc. now owns 140,551 shares of the company’s stock valued at $6,880,000 after buying an additional 87,107 shares during the last quarter. Opal Capital LLC bought a new stake in shares of Roche in the 1st quarter valued at about $4,448,000. Hantz Financial Services Inc. increased its stake in shares of Roche by 164.9% in the fourth quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock valued at $4,112,000 after buying an additional 49,633 shares during the period. Finally, Enterprise Financial Services Corp raised its position in shares of Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after acquiring an additional 345 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.